These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25568334)

  • 1. Inactivation of GSK3β and activation of NF-κB pathway via Axl represents an important mediator of tumorigenesis in esophageal squamous cell carcinoma.
    Paccez JD; Duncan K; Vava A; Correa RG; Libermann TA; Parker MI; Zerbini LF
    Mol Biol Cell; 2015 Mar; 26(5):821-31. PubMed ID: 25568334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target.
    Paccez JD; Vasques GJ; Correa RG; Vasconcellos JF; Duncan K; Gu X; Bhasin M; Libermann TA; Zerbini LF
    Oncogene; 2013 Feb; 32(6):689-98. PubMed ID: 22410775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated macrophages promote oral cancer progression through activation of the Axl signaling pathway.
    Lee CH; Liu SY; Chou KC; Yeh CT; Shiah SG; Huang RY; Cheng JC; Yen CY; Shieh YS
    Ann Surg Oncol; 2014 Mar; 21(3):1031-7. PubMed ID: 24276640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axl is a prognostic marker in oral squamous cell carcinoma.
    Lee CH; Yen CY; Liu SY; Chen CK; Chiang CF; Shiah SG; Chen PH; Shieh YS
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S500-8. PubMed ID: 21842265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polarization of tumor-associated macrophages and Gas6/Axl signaling in oral squamous cell carcinoma.
    Chiu KC; Lee CH; Liu SY; Chou YT; Huang RY; Huang SM; Shieh YS
    Oral Oncol; 2015 Jul; 51(7):683-9. PubMed ID: 25910588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein S drives oral squamous cell carcinoma tumorigenicity through regulation of AXL.
    Abboud-Jarrous G; Priya S; Maimon A; Fischman S; Cohen-Elisha M; Czerninski R; Burstyn-Cohen T
    Oncotarget; 2017 Feb; 8(8):13986-14002. PubMed ID: 28118606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qigesan reduces the motility of esophageal cancer cells via inhibiting Gas6/Axl and NF-κB expression.
    Kong L; Wu Z; Zhao Y; Lu X; Shi H; Liu S; Li J
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31110076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p.
    Li YY; Tao YW; Gao S; Li P; Zheng JM; Zhang SE; Liang J; Zhang Y
    EBioMedicine; 2018 Oct; 36():209-220. PubMed ID: 30243489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells.
    Shin WS; Hong Y; Lee HW; Lee ST
    Oncotarget; 2016 Nov; 7(45):73242-73256. PubMed ID: 27689325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AXL Mediates Esophageal Adenocarcinoma Cell Invasion through Regulation of Extracellular Acidification and Lysosome Trafficking.
    Maacha S; Hong J; von Lersner A; Zijlstra A; Belkhiri A
    Neoplasia; 2018 Oct; 20(10):1008-1022. PubMed ID: 30189359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas.
    Elkabets M; Pazarentzos E; Juric D; Sheng Q; Pelossof RA; Brook S; Benzaken AO; Rodon J; Morse N; Yan JJ; Liu M; Das R; Chen Y; Tam A; Wang H; Liang J; Gurski JM; Kerr DA; Rosell R; Teixidó C; Huang A; Ghossein RA; Rosen N; Bivona TG; Scaltriti M; Baselga J
    Cancer Cell; 2015 Apr; 27(4):533-46. PubMed ID: 25873175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
    Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
    Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
    Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
    Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ING5 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through regulation of the Akt/NF-κB/MMP-9 signaling pathway.
    Zhang GJ; Zhao J; Jiang ML; Zhang LC
    Biochem Biophys Res Commun; 2018 Feb; 496(2):387-393. PubMed ID: 29326045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-kappaB and Brg-1.
    Tai KY; Shieh YS; Lee CS; Shiah SG; Wu CW
    Oncogene; 2008 Jul; 27(29):4044-55. PubMed ID: 18345028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma.
    Hector A; Montgomery EA; Karikari C; Canto M; Dunbar KB; Wang JS; Feldmann G; Hong SM; Haffner MC; Meeker AK; Holland SJ; Yu J; Heckrodt TJ; Zhang J; Ding P; Goff D; Singh R; Roa JC; Marimuthu A; Riggins GJ; Eshleman JR; Nelkin BD; Pandey A; Maitra A
    Cancer Biol Ther; 2010 Nov; 10(10):1009-18. PubMed ID: 20818175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA LINC00526 represses glioma progression via forming a double negative feedback loop with AXL.
    Yan J; Xu C; Li Y; Tang B; Xie S; Hong T; Zeng E
    J Cell Mol Med; 2019 Aug; 23(8):5518-5531. PubMed ID: 31240814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3β.
    Liu RM; Sun DN; Jiao YL; Wang P; Zhang J; Wang M; Ma J; Sun M; Gu BL; Chen P; Liu K; Ma H; Gao SG; Ma YF; Qi YJ
    Cancer Lett; 2018 Jan; 412():289-296. PubMed ID: 29079416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma.
    Liu R; Gong M; Li X; Zhou Y; Gao W; Tulpule A; Chaudhary PM; Jung J; Gill PS
    Blood; 2010 Jul; 116(2):297-305. PubMed ID: 20442363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma.
    Hsieh MS; Yang PW; Wong LF; Lee JM
    Oncotarget; 2016 Jun; 7(24):36956-36970. PubMed ID: 27172793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.